This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zarazaga, M.
Right arrow Articles by Torres, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zarazaga, M.
Right arrow Articles by Torres, C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2002, p. 3657-3659, Vol. 46, No. 11
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.11.3657-3659.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Mutations in Ribosomal Protein L16 and in 23S rRNA in Enterococcus Strains for Which Evernimicin MICs Differ

Myriam Zarazaga, Carmen Tenorio, Rosa Del Campo, Fernanda Ruiz-Larrea, and Carmen Torres*

Área de Bioquímica y Biología Molecular, Universidad de La Rioja, Logroño, Spain

Received 2 April 2002/ Returned for modification 23 May 2002/ Accepted 26 July 2002


arrow
ABSTRACT
 
Mutations in ribosomal protein L16 and in 23S rRNA were investigated in 22 Enterococcus strains of different species and for which the MICs of evernimicin differ (MICs, 0.023 to 16 µg/ml). Amino acid changes (Arg56His, Ile52Thr, or Arg51His) in protein L16 were found in seven strains, and a nucleotide G2535A mutation in 23S rRNA was found in 1 strain among 13 for which the MICs are >=1 µg/ml.


arrow
TEXT
 
Evernimicin (SCH-27899) (EVN) is an oligosaccharide antibiotic with excellent activity against a broad range of gram-positive pathogenic bacteria (7, 12). This antibiotic inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit (5, 9). Different mechanisms of EVN resistance have been reported to date: (i) mutations in the rplP gene that encodes the ribosomal protein L16 (detected in Streptococcus pneumoniae [3], Enterococcus faecalis and Enterococcus faecium animal isolates [1], and mutants of Staphylococcus aureus [10]; (ii) mutations in domain V of 23S rRNA gene (detected in S. pneumoniae [2] and Halobacterium halobium isolates [5]); and (iii) synthesis of an rRNA methyltransferase (EmtA) that confers high-level EVN resistance (detected in an E. faecium animal strain [8]). The number of rRNA operons (rrn) in enterococci has been previously estimated between five and six, depending upon the species (6, 11).

The objective of this study was to analyze the sequences of the ribosomal L16 proteins and of the 23S rRNA genes of 19 Enterococcus strains that were chosen from our collection of strains on the basis of their increased EVN MIC (MIC range, 0.75 to 16 µg/ml). Enterococcus strains were recovered from feces of healthy animals (12 E. faecium strains, two E. faecalis strains, four Enterococcus hirae strains, and one Enterococcus durans strain). Three additional strains (one strain each of E. faecium, E. faecalis, and E. hirae) for which the MICs of EVN were in the range 0.023 to 0.19 µg/ml were also included as control susceptible strains. All 22 strains in this study showed an unrelated pulsed-field gel electrophoresis pattern after SmaI digestion (data not shown). MICs of EVN were determined by the E-test method following the manufacturer's guidelines (AB Biodisk, Solna, Sweden).

A fragment of 414 bp of the gene that encodes the ribosomal protein L16 and a 634-bp fragment of the domain V of the 23S rRNA gene that includes the peptidyltransferase region were amplified by PCR in all 22 strains using primers previously described (1, 13). Amplicons were purified and sequenced in both strands using the same primers as those used for PCRs. The 23S rRNA gene was numbered following Escherichia coli position numbering. The nucleotide sequences obtained for both genes were compared with the reference sequences indicated in Table 1.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Sequences used as reference for the study of mutations in the rplP gene that encodes the ribosomal protein L16 and in the 23S rRNA gene

Results of EVN MICs as well as the mutations detected in both rplP and 23S rRNA genes in the 22 strains of this study are shown in Table 2.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Mutations in the rplP gene that encodes the ribosomal L16 protein and in the 23S rRNA gene in Enterococcus strains for which the MICs of EVN differ

E. faecium. No amino acid substitutions in ribosomal protein L16 were predicted from the sequences obtained from the six E. faecium strains for which the MIC of EVN was <= 0.75 µg/ml. Nevertheless, amino acid changes (Arg56His and Ile52Thr) were predicted in five of seven strains for which the MICs of EVN were in the range 1 to 3 µg/ml. These changes in protein L16 had been previously reported in E. faecium isolates for which the MICs of EVN were >=3 µg/ml (1). Different silent mutations in the rplP gene were also identified in three of the analyzed strains (Table 2).

Twelve of the 13 strains showed the same wild-type sequence as that previously reported (GenBank accession no. AJ295305) when 23S rRNA amplicons were sequenced and analyzed. One of the strains showed the mutation A2211G (Table 2), but this mutation was included in another previously published sequence (GenBank accession no. X79341). The position 2211 is located in hairpin 79 of domain V of the 23S rRNA gene, and this place is far away of the binding site of EVN to the 50S ribosomal subunit (5).

E. faecalis. The mutation encoding the Arg51His change was observed in L16 protein of the strain Z-123 (MIC, 8 µg/ml). To our knowledge, the Arg51His substitution has not been described to date in Enterococcus and also has not been reported as a spontaneous change in any microorganism. Position 51 of protein L16 seems to be important for EVN action. The Arg51His or Arg51Cys changes have been previously obtained by chemical mutagenesis in S. aureus, causing a marked increase in the MIC of EVN (30 or 60 times, respectively) with respect to the wild-type strain (10). In addition, the Arg51Cys change has also been reported in S. pneumoniae mutants obtained by site-directed mutagenesis (3). No predicted amino acid changes in protein L16 were identified in strains Z-68 and Z-37 (EVN MICs, 0.19 and 16 µg/ml, respectively) (Table 2).

Clear single-nucleotide peaks were obtained in all chromatograms when the 23S rRNA amplicons were sequenced, and that suggests the presence of the same sequence in all fragments of rrn operons in our strains. A nucleotide mutation G2581A (with respect to the sequence AJ295306) was identified in the 23S rRNA amplicons of our three E. faecalis strains. The nucleotide at position 2581 is far from the EVN binding site in the ribosomal 50S subunit (4, 5), and thus, a mutation in this nucleotide could not be related to the increase in the MIC of EVN. A G2535A transition in the 23S rRNA gene was detected in E. faecalis isolate Z-37 (MIC, 16 µg/ml). This point mutation causes the disappearance of a target for the AvaII enzyme. A wild-type gene should give rise to three fragments (552, 72, and 10 bp) while a G2535A-mutated gene would yield two fragments (624 and 10 bp). The analysis of the restriction fragment length polymorphism pattern of the amplicon after AvaII digestion suggests that all copies of the 23S rRNA gene are mutated in the Z-37 strain (data not shown). This nucleotide mutation has been associated with an increase in the MIC of EVN for isolates of S. pneumoniae (2) and H. halobium (5), but never before for Enterococcus. Other nucleotide mutations in 23S rRNA gene (at positions 2536, 2469, and 2480) associated with increased MICs or EVN for S. pneumoniae isolates have also been reported (2).

E. hirae. Five E. hirae strains were analyzed in this study; for four of these the MICs of EVN were in the range 0.75 to 2 µg/ml, and there was one susceptible control strain for which the MIC was 0.19 µg/ml. The sequences of the rplP gene have been compared to that from E. faecium (Table 1). All five strains studied, including the very susceptible one, showed a predicted Pro110Ser change in the protein L16. Thus, this change does not seem to be related to an increase in the MIC of EVN. A second amino acid change (Arg56His) was predicted in E. hirae Z-89 strain (MIC, 2 µg/ml). Different silent mutations were detected in the rplP gene that encodes protein L16 in all E. hirae isolates. No nucleotide mutations were identified in the partial 23S rRNA gene sequenced of the 5 E. hirae strains studied.

E. durans. No amino acid changes in L16 ribosomal protein (compared to wild-type L16 protein of E. faecium AF291861) and no nucleotide mutations in the 23S rRNA gene were identified in the single E. durans isolate analyzed in this study (MIC of EVN, 2 µg/ml).

As a conclusion, an Arg51His change in the L16 protein and a G2535A mutation in the 23S rRNA gene have been detected in two E. faecalis strains, and these mutations could be associated with the high MICs of EVN (8 and 16 µg/ml) for these strains. To our knowledge, this is the first time that these mutations have been reported in Enterococcus. Amino acid changes in the L16 protein or nucleotide mutations in the 23S rRNA gene were detected as being a presumable EVN resistance mechanism in 8 strains among 13 for which the MICs were >=1 µg/ml. Other mechanisms of resistance (such as the EmtA rRNA methyltransferase) should be sought in the remaining 5 strains for which the MICs of EVN are increased.


arrow
ACKNOWLEDGMENTS
 
This work was supported in part by the grants of the Fondo de Investigaciones Sanitarias (FIS 01/0973) and by the Consejería de Educación del Gobierno de La Rioja (ACPI2000/021) of Spain. The E-test strips were kindly supplied by Schering-Plough Research Institute, Bloomfield, N.J.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Area de Bioquímica y Biología Molecular, Universidad de La Rioja, Madre de Dios, 51, 26006 Logroño, Spain. Phone: 34-941299750. Fax: 34-941299721. E-mail: carmen.torres{at}daa.unirioja.es. Back


arrow
REFERENCES
 
    1
  1. Aarestrup, F. M., and L. B. Jensen. 2000. Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (avilamycin and evernimicin). Antimicrob. Agents Chemother. 44:3425-3427.[Abstract/Free Full Text]
    2. 2
  2. Adrian, P. V., C. Mendrick, D. Loebenberg, P. McNicholas, K. J. Shaw, K. P. Klugman, R. S. Hare, and T. A. Black. 2000. Evernimicin (SCH27899) inhibits a novel ribosome target site: analysis of 23S ribosomal DNA mutants. Antimicrob. Agents Chemother. 44:3101-3106.[Abstract/Free Full Text]
    3. 3
  3. Adrian, P. V., W. Zhao, T. A. Black, K. J. Shaw, R. S. Hare, and K. P. Kludman. 2000. Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action. Antimicrob. Agents Chemother. 44:732-738.[Abstract/Free Full Text]
    4. 4
  4. Ban, N., P. Nissen, J. Hansen, P. B. Moore, and T. A. Steitz. 2000. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science 289:905-920.[Abstract/Free Full Text]
    5. 5
  5. Belova, L., T. Tenson, L. Xiong, P. M. McNicholas, and A. S. Mankin. 2001. A novel site of antibiotic action in the ribosome: interaction of evernimicin, a protein synthesis inhibitor, with the large ribosomal subunit. Proc. Natl. Acad. Sci. USA 98:3726-3731.[Abstract/Free Full Text]
    6. 6
  6. Gürtler, V. 1999. The role of recombination and mutation in 16S-23S rDNA spacer rearrangements. Gene 238:241-252.[CrossRef][Medline]
    7. 7
  7. Jones, R. N., and M. S. Barrett. 1995. Antimicrobial activity of evernimicin, oligosaccharide member of the everninomicin class with a wide Gram-positive spectrum. J. Clin. Microbiol. Infect. 1:35-43.
    8. 8
  8. Mann, P. A., L. Xiong, A. S. Mankin, A. S. Chau, C. A. Mendrick, D. J. Najarian, C. A. Cramer, D. Loebenberg, E. Coates, N. J. Murgolo, F. M. Aarestrup, R. V. Goering, T. A. Black, R. S. Hare, and P. M. McNicholas. 2001. EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance. Mol. Microbiol. 41:1349-1356.[CrossRef][Medline]
    9. 9
  9. McNicholas, P. M., D. J. Najarian, P. A. Mann, P. A. Hesk, R. S. Hare, K. J. Shaw, and T. A. Black. 2000. Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell free systems derived from both gram positive and gram negative bacteria. Antimicrob. Agents Chemother. 44:1121-1126.[Abstract/Free Full Text]
    10. 10
  10. McNicholas, P. M., P. A. Mann, D. J. Najarian, L. Miesel, R. S. Hare, and T. A. Black. 2001. Effects of mutations in ribosomal protein L16 on susceptibility and accumulation of evernimicin. Antimicrob. Agents Chemother. 45:79-83.[Abstract/Free Full Text]
    11. 11
  11. Sechi, L. A., F. M. Zuccon, J. E. Mortensen, and L. Daneo-Moore. 1994. Ribosomal RNA gene (rrn) organization in enterococci. FEMS Microbiol. Lett. 120:307-313.[CrossRef][Medline]
    12. 12
  12. Terakubo, S., H. Takemura, H. Yamamoto, H. Ikejima, H. Kunishima, K. Kanemitsu, M. Kaku, and J. Shimada. 2001. Antimicrobial activity of everninomicin against clinical isolates of Enterococcus spp., Staphylococcus spp., and Streptococcus spp. tested by E-test. J. Infect. Chemother. 7:263-266.[CrossRef][Medline]
    13. 13
  13. Tsiodras, S., H. S. Gold, E. P. Coakley, C. Wennersten, R. C. Moellering, Jr., and G. M. Eliopoulos. 2000. Diversity of domain V of 23S rRNA gene sequence in different Enterococcus species. J. Clin. Microbiol. 38:3991-3993.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, November 2002, p. 3657-3659, Vol. 46, No. 11
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.11.3657-3659.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Petsaris, O., Miszczak, F., Gicquel-Bruneau, M., Perrin-Guyomard, A., Humbert, F., Sanders, P., Leclercq, R. (2005). Combined Antimicrobial Resistance in Enterococcus faecium Isolated from Chickens. Appl. Environ. Microbiol. 71: 2796-2799 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zarazaga, M.
Right arrow Articles by Torres, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zarazaga, M.
Right arrow Articles by Torres, C.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»